<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Experimental HIV vaccine “deeply disappoints” in South Africa trial &#8211; Healthcare Asia Daily News &#8211; Asia&#039;s Leading News and Information Source on Healthcare and Medical Industry, Medical Technology, Healthcare Business and R&amp;D, Healthcare Events. Online since 2010</title>
	<atom:link href="https://www.healthcareasia.org/tag/experimental-hiv-vaccine-deeply-disappoints-in-south-africa-trial/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.healthcareasia.org</link>
	<description>Connecting people to news &#38; information on Asian healthcare</description>
	<lastBuildDate>Fri, 07 Feb 2020 03:03:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.healthcareasia.org/wp-content/uploads/2025/04/cropped-favicon-32x32.png</url>
	<title>Experimental HIV vaccine “deeply disappoints” in South Africa trial &#8211; Healthcare Asia Daily News &#8211; Asia&#039;s Leading News and Information Source on Healthcare and Medical Industry, Medical Technology, Healthcare Business and R&amp;D, Healthcare Events. Online since 2010</title>
	<link>https://www.healthcareasia.org</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Experimental HIV vaccine “deeply disappoints” in South Africa trial</title>
		<link>https://www.healthcareasia.org/2020/experimental-hiv-vaccine-deeply-disappoints-in-south-africa-trial/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 07 Feb 2020 03:03:55 +0000</pubDate>
				<category><![CDATA[Community]]></category>
		<category><![CDATA[Features]]></category>
		<category><![CDATA[Experimental HIV vaccine “deeply disappoints” in South Africa trial]]></category>
		<guid isPermaLink="false">http://www.healthcareasia.org/?p=33452</guid>

					<description><![CDATA[An experimental vaccine trial of some 5,000 people in South Africa has just been stopped by The National Institutes of Health (NIH) as it found the jab did not prevent the HIV virus that causes the deadly acquired immune deficiency [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>An experimental vaccine trial of some 5,000 people in South Africa has just been stopped by The National Institutes of Health (NIH) as it found the jab did not prevent the HIV virus that causes the deadly acquired immune deficiency syndrome (AIDS). The HVTN 702 trial involved the most promising HIV-vaccine yet – it was first shown to provide some protection against a particular strain of the virusin the RV144 clinical trial in Thailand; and was subsequently adapted to the subtype most common in South Africa, which has one of the highest HIV rates in the world.</p>



<div class="wp-block-image"><figure class="aligncenter"><img fetchpriority="high" decoding="async" width="448" height="400" src="https://www.healthcareasia.org/wp-content/uploads/2020/02/HIV.jpg" alt="" class="wp-image-33453" srcset="https://www.healthcareasia.org/wp-content/uploads/2020/02/HIV.jpg 448w, https://www.healthcareasia.org/wp-content/uploads/2020/02/HIV-300x268.jpg 300w" sizes="(max-width: 448px) 100vw, 448px" /></figure></div>



<p>Dr. Anthony Fauci, from the NIH, was disappointed,
&#8220;Regrettably, this vaccine does not work.” However, “research continues on
other approaches to a safe and effective HIV vaccine,” which Dr. Fauci still
believes can be achieved. This follows his review of patients in the HVTN 702 trial
who were still susceptible to HIV/AIDS despite being given the vaccine.</p>



<p>An effective HIV vaccine does not contain HIV nor pose any
danger of giving HIV to its recipient.Alongside recent breakthroughs in
anti-retroviral treatments that have improved the lifespan of people with HIV,
a drug treatment called pre-exposure prophylaxis (Prep) seems effective in
preventing HIV infection but, unlike a vaccine, it needs to be taken daily. In
countries where such treatments may not be available, the only effective
prevention remains using condoms during sexual intercourse or outright
abstinence.</p>



<p>Debbie Laycock, Head of Policy at British charity Terrence Higgins Trust (THT) said, &#8220;Regular testing, condoms, Prep and effective treatment means people living with HIV can&#8217;t pass on the virus – it’s vital we seize this opportunity to end the HIV epidemic.”</p>



<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- Right sidebar -->
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-2954961888212505"
     data-ad-slot="7181491453"
     data-ad-format="auto"
     data-full-width-responsive="true"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
